Product References
The human intermediate prolactin receptor is a mammary proto-oncogene.
NPJ breast cancer
Grible JM,Zot P,Olex AL,Hedrick SE,Harrell JC,Woock AE,Idowu MO,Clevenger CV
Published figure using Prolactin Receptor monoclonal antibody (Product # 35-9200) in Western Blot
Fri Mar 26 00:00:00 UTC 2021
The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
Theranostics
Nie H,Huang PQ,Jiang SH,Yang Q,Hu LP,Yang XM,Li J,Wang YH,Li Q,Zhang YF,Zhu L,Zhang YL,Yu Y,Xiao GG,Sun YW,Ji J,Zhang ZG
35-9200 was used in Neutralization to investigate the role and underlying mechanism of PRLR-SF in pancreatic ductal adenocarcinoma (PDAC).
Thu Jul 29 00:00:00 UTC 2021
RAB6 GTPase regulates mammary secretory function by controlling the activation of STAT5.
Development (Cambridge, England)
Cayre S,Faraldo MM,Bardin S,Miserey-Lenkei S,Deugnier MA,Goud B
35-9200 was used in Western Blot, Immunocytochemistry to reveal a crucial role for RAB6A/A' in the lactogenic function of the mammary gland and suggest that the trafficking pathways controlled by RAB6A/A' depend on cell-type specialization and tissue context.
Thu Oct 08 00:00:00 UTC 2020
RAB6 GTPase regulates mammary secretory function by controlling the activation of STAT5.
Development (Cambridge, England)
Cayre S,Faraldo MM,Bardin S,Miserey-Lenkei S,Deugnier MA,Goud B
35-9200 was used in Western Blot, Immunocytochemistry to reveal a crucial role for RAB6A/A' in the lactogenic function of the mammary gland and suggest that the trafficking pathways controlled by RAB6A/A' depend on cell-type specialization and tissue context.
Thu Oct 08 00:00:00 UTC 2020
RAB6 GTPase regulates mammary secretory function by controlling the activation of STAT5.
Development (Cambridge, England)
Cayre S,Faraldo MM,Bardin S,Miserey-Lenkei S,Deugnier MA,Goud B
35-9200 was used in Western Blot, Immunocytochemistry to reveal a crucial role for RAB6A/A' in the lactogenic function of the mammary gland and suggest that the trafficking pathways controlled by RAB6A/A' depend on cell-type specialization and tissue context.
Thu Oct 08 00:00:00 UTC 2020
RAB6 GTPase regulates mammary secretory function by controlling the activation of STAT5.
Development (Cambridge, England)
Cayre S,Faraldo MM,Bardin S,Miserey-Lenkei S,Deugnier MA,Goud B
35-9200 was used in Western Blot, Immunocytochemistry to reveal a crucial role for RAB6A/A' in the lactogenic function of the mammary gland and suggest that the trafficking pathways controlled by RAB6A/A' depend on cell-type specialization and tissue context.
Thu Oct 08 00:00:00 UTC 2020
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs.
Molecular cancer therapeutics
Andreev J,Thambi N,Perez Bay AE,Delfino F,Martin J,Kelly MP,Kirshner JR,Rafique A,Kunz A,Nittoli T,MacDonald D,Daly C,Olson W,Thurston G
35-9200 was used in western blot to compare HER2 and prolactin receptor trafficking
Sat Apr 01 00:00:00 UTC 2017
The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.
Journal of the National Cancer Institute
Sutherland A,Forsyth A,Cong Y,Grant L,Juan TH,Lee JK,Klimowicz A,Petrillo SK,Hu J,Chan A,Boutillon F,Goffin V,Egan C,Tang PA,Cai L,Morris D,Magliocco A,Shemanko CS
359200 was used in immunohistochemistry to test if prolactin alters the secondary tumor bone microenvironment
Tue Mar 01 00:00:00 UTC 2016
The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation.
Rheumatology (Oxford, England)
Tang MW,Reedquist KA,Garcia S,Fernandez BM,Codullo V,Vieira-Sousa E,Goffin V,Reuwer AQ,Twickler MT,Gerlag DM,Tak PP
359200 was used in immunohistochemistry to assess the expression of prolactin by synovial macrophages and determine if prolactin alters macrophage activation
Thu Dec 01 00:00:00 UTC 2016
Gain-of-function Prolactin Receptor Variants Are Not Associated With Breast Cancer and Multiple Fibroadenoma Risk.
The Journal of clinical endocrinology and metabolism
Chakhtoura Z,Laki F,Bernadet M,Cherifi I,Chiche A,Pigat N,Bernichtein S,Courtillot C,Boutillon F,Bièche I,Vacher S,Tanguy ML,Bissery A,Grouthier V,Camparo P,Foretz M,Do Cruzeiro M,Pierre R,Rakotozafy F,Tichet J,Tejedor I,Guidotti JE,Sigal-Zafrani B,Goffin V,Touraine P
359200 was used in immunohistochemistry - paraffin section to identify a prolactin receptor mutation in 95 cases of multiple breast fibroadenomas
Tue Nov 01 00:00:00 UTC 2016
Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin.
Medicine
Legorreta-Haquet MV,Chávez-Rueda K,Chávez-Sánchez L,Cervera-Castillo H,Zenteno-Galindo E,Barile-Fabris L,Burgos-Vargas R,Álvarez-Hernández E,Blanco-Favela F
359200 was used in flow cytometry to examine the relationship between prolactin and T regulatory cells in patients with systemic lupus erythematosus
Mon Feb 01 00:00:00 UTC 2016
Role of Prolactin Receptors in Lymphangioleiomyomatosis.
PloS one
Alkharusi A,Lesma E,Ancona S,Chiaramonte E,Nyström T,Gorio A,Norstedt G
35-9200 was used in immunocytochemistry, immunohistochemistry - paraffin section, and western blot to study lymphangioleiomyomatosis and the role of prolactin receptors
Tue Jul 26 00:00:00 UTC 2016
Role of Prolactin Receptors in Lymphangioleiomyomatosis.
PloS one
Alkharusi A,Lesma E,Ancona S,Chiaramonte E,Nyström T,Gorio A,Norstedt G
35-9200 was used in immunocytochemistry, immunohistochemistry - paraffin section, and western blot to study lymphangioleiomyomatosis and the role of prolactin receptors
Tue Jul 26 00:00:00 UTC 2016
Role of Prolactin Receptors in Lymphangioleiomyomatosis.
PloS one
Alkharusi A,Lesma E,Ancona S,Chiaramonte E,Nyström T,Gorio A,Norstedt G
35-9200 was used in immunocytochemistry, immunohistochemistry - paraffin section, and western blot to study lymphangioleiomyomatosis and the role of prolactin receptors
Tue Jul 26 00:00:00 UTC 2016
Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme.
Oncotarget
Alkharusi A,Yu S,Landázuri N,Zadjali F,Davodi B,Nyström T,Gräslund T,Rahbar A,Norstedt G
35-9200 was used in Immunocytochemistry-immunoflourescence to investigate components of the prolactin system in cell models and histological tissue sections from glioblastoma multiforme.
Tue Nov 29 00:00:00 UTC 2016
Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells.
Oncotarget
Barcus CE,Keely PJ,Eliceiri KW,Schuler LA
359200 was used in western blot to explore the extracellular matrix features that control prolactin signals
Tue Jul 26 00:00:00 UTC 2016
Blockade of estrogen-stimulated proliferation by a constitutively-active prolactin receptor having lower expression in invasive ductal carcinoma.
Cancer letters
Huang KT,Tan D,Chen KE,Walker AM
35-9200 was used in western blot to study the role of prolactin and its receptors in breast cancer
Sat Mar 28 00:00:00 UTC 2015
Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
PloS one
Barcus CE,Holt EC,Keely PJ,Eliceiri KW,Schuler LA
Published figure using Prolactin Receptor monoclonal antibody (Product # 35-9200) in Western Blot
Mon Jan 04 00:00:00 UTC 2016
Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.
Hormones & cancer
Faupel-Badger JM,Duggan MA,Sherman ME,Garcia-Closas M,Yang XR,Lissowska J,Brinton LA,Peplonska B,Vonderhaar BK,Figueroa JD
Published figure using Prolactin Receptor monoclonal antibody (Product # 35-9200) in Immunohistochemistry
Sat Feb 01 00:00:00 UTC 2014
Characterization of Δ7/11, a functional prolactin-binding protein.
Journal of molecular endocrinology
Fleming JM,Ginsburg E,McAndrew CW,Heger CD,Cheston L,Rodriguez-Canales J,Vonderhaar BK,Goldsmith P
Published figure using Prolactin Receptor monoclonal antibody (Product # 35-9200) in Immunoprecipitation
Fri Feb 01 00:00:00 UTC 2013
Characterization of Δ7/11, a functional prolactin-binding protein.
Journal of molecular endocrinology
Fleming JM,Ginsburg E,McAndrew CW,Heger CD,Cheston L,Rodriguez-Canales J,Vonderhaar BK,Goldsmith P
Published figure using Prolactin Receptor monoclonal antibody (Product # 35-9200) in Immunoprecipitation
Fri Feb 01 00:00:00 UTC 2013
Characterization of Δ7/11, a functional prolactin-binding protein.
Journal of molecular endocrinology
Fleming JM,Ginsburg E,McAndrew CW,Heger CD,Cheston L,Rodriguez-Canales J,Vonderhaar BK,Goldsmith P
Published figure using Prolactin Receptor monoclonal antibody (Product # 35-9200) in Immunoprecipitation
Fri Feb 01 00:00:00 UTC 2013
Characterization of Δ7/11, a functional prolactin-binding protein.
Journal of molecular endocrinology
Fleming JM,Ginsburg E,McAndrew CW,Heger CD,Cheston L,Rodriguez-Canales J,Vonderhaar BK,Goldsmith P
Published figure using Prolactin Receptor monoclonal antibody (Product # 35-9200) in Immunoprecipitation
Fri Feb 01 00:00:00 UTC 2013
Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer.
Breast cancer research and treatment
Nitze LM,Galsgaard ED,Din N,Lund VL,Rasmussen BB,Berchtold MW,Christensen L,Panina S
35-9200 was used in western blot to investigate the role of prolactin in breast cancer
Fri Nov 01 00:00:00 UTC 2013
Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer.
Breast cancer research and treatment
Nitze LM,Galsgaard ED,Din N,Lund VL,Rasmussen BB,Berchtold MW,Christensen L,Panina S
35-9200 was used in western blot to investigate the role of prolactin in breast cancer
Fri Nov 01 00:00:00 UTC 2013
Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.
The Journal of biological chemistry
Barcus CE,Keely PJ,Eliceiri KW,Schuler LA
35-9200 was used in western blot to study the involvement of collagen matrices in tumorigenic prolactin signaling in breast cancer cells
Fri May 03 00:00:00 UTC 2013
Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.
The Journal of biological chemistry
Barcus CE,Keely PJ,Eliceiri KW,Schuler LA
35-9200 was used in western blot to study the involvement of collagen matrices in tumorigenic prolactin signaling in breast cancer cells
Fri May 03 00:00:00 UTC 2013
Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?
Journal of cellular and molecular medicine
Reuwer AQ,Nowak-Sliwinska P,Mans LA,van der Loos CM,von der Thüsen JH,Twickler MT,Spek CA,Goffin V,Griffioen AW,Borensztajn KS
35-9200 was used in immunohistochemistry to investigate the functions of prolactin in endothelial cells and its involvement in pathological angiogenesis.
Sat Sep 01 00:00:00 UTC 2012
Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
Cancer letters
Tan D,Chen KE,Khoo T,Walker AM
35-9200 was used in western blot to investigate variably-spliced prolactin receptors.
Tue Nov 01 00:00:00 UTC 2011
The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis?
The Journal of endocrinology
Reuwer AQ,van Eijk M,Houttuijn-Bloemendaal FM,van der Loos CM,Claessen N,Teeling P,Kastelein JJ,Hamann J,Goffin V,von der Thüsen JH,Twickler MT,Aten J
35-9200 was used in immunohistochemistry - paraffin section to investigate the localization of the prolactin receptor in atherosclerotic plaques
Tue Feb 01 00:00:00 UTC 2011
Functional impact of manipulation on the relative orientation of human prolactin receptor domains.
Biochemistry
Liu W,Brooks CL
35-9200 was used in immunohistochemistry to examine the rotation model of the human prolactin receptor.
Tue Jun 14 00:00:00 UTC 2011
Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
Endocrine-related cancer
Rasmussen LM,Frederiksen KS,Din N,Galsgaard E,Christensen L,Berchtold MW,Panina S
35-9200 was used in western blot to study the interaction between prolactin and oestrogen in breast cancer cells
Wed Sep 01 00:00:00 UTC 2010
Identification of gain-of-function variants of the human prolactin receptor.
Methods in enzymology
Goffin V,Bogorad RL,Touraine P
35-9200 was used in western blot to discuss how prolactin receptor variants were discovered as contributors of breast cancer
Tue Feb 08 00:00:00 UTC 2011
Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.
The Journal of biological chemistry
Carver KC,Piazza TM,Schuler LA
35-9200 was used in western blot to elucidate the mechanism of cross-talk between PRL and IGF-I in breast cancer cells
Fri Mar 12 00:00:00 UTC 2010
Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.
The Journal of biological chemistry
Carver KC,Piazza TM,Schuler LA
35-9200 was used in western blot to elucidate the mechanism of cross-talk between PRL and IGF-I in breast cancer cells
Fri Mar 12 00:00:00 UTC 2010
Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.
The Journal of biological chemistry
Carver KC,Piazza TM,Schuler LA
35-9200 was used in western blot to elucidate the mechanism of cross-talk between PRL and IGF-I in breast cancer cells
Fri Mar 12 00:00:00 UTC 2010
Azaspiracid-1 inhibits endocytosis of plasma membrane proteins in epithelial cells.
Toxicological sciences : an official journal of the Society of Toxicology
Bellocci M,Sala GL,Callegari F,Rossini GP
35-9200 was used in Western Blotting to demonstrate that azaspiracid-1 inhibits endocytosis of plasma membrane proteins in epithelial cells.
Wed Sep 01 00:00:00 UTC 2010
Re-evaluation of the prolactin receptor expression in human breast cancer.
The Journal of endocrinology
Galsgaard ED,Rasmussen BB,Folkesson CG,Rasmussen LM,Berchtold MW,Christensen L,Panina S
Wed Apr 01 00:00:00 UTC 2009
Re-evaluation of the prolactin receptor expression in human breast cancer.
The Journal of endocrinology
Galsgaard ED,Rasmussen BB,Folkesson CG,Rasmussen LM,Berchtold MW,Christensen L,Panina S
Wed Apr 01 00:00:00 UTC 2009
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
Proceedings of the National Academy of Sciences of the United States of America
Bogorad RL,Courtillot C,Mestayer C,Bernichtein S,Harutyunyan L,Jomain JB,Bachelot A,Kuttenn F,Kelly PA,Goffin V,Touraine P
Tue Sep 23 00:00:00 UTC 2008
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
Proceedings of the National Academy of Sciences of the United States of America
Bogorad RL,Courtillot C,Mestayer C,Bernichtein S,Harutyunyan L,Jomain JB,Bachelot A,Kuttenn F,Kelly PA,Goffin V,Touraine P
Tue Sep 23 00:00:00 UTC 2008
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
Proceedings of the National Academy of Sciences of the United States of America
Bogorad RL,Courtillot C,Mestayer C,Bernichtein S,Harutyunyan L,Jomain JB,Bachelot A,Kuttenn F,Kelly PA,Goffin V,Touraine P
Tue Sep 23 00:00:00 UTC 2008
Polyubiquitination of prolactin receptor stimulates its internalization, postinternalization sorting, and degradation via the lysosomal pathway.
Molecular and cellular biology
Varghese B,Barriere H,Carbone CJ,Banerjee A,Swaminathan G,Plotnikov A,Xu P,Peng J,Goffin V,Lukacs GL,Fuchs SY
35-9200 was used in western blot to study the mechanisms of PRL receptor proteolysis
Mon Sep 01 00:00:00 UTC 2008
Polyubiquitination of prolactin receptor stimulates its internalization, postinternalization sorting, and degradation via the lysosomal pathway.
Molecular and cellular biology
Varghese B,Barriere H,Carbone CJ,Banerjee A,Swaminathan G,Plotnikov A,Xu P,Peng J,Goffin V,Lukacs GL,Fuchs SY
35-9200 was used in western blot to study the mechanisms of PRL receptor proteolysis
Mon Sep 01 00:00:00 UTC 2008
Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter.
BMC biotechnology
Fang F,Antico G,Zheng J,Clevenger CV
Wed Feb 06 00:00:00 UTC 2008
A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone.
Endocrine-related cancer
Ueda E,Ozerdem U,Chen YH,Yao M,Huang KT,Sun H,Martins-Green M,Bartolini P,Walker AM
35-9200 was used in immunoprecipitation and western blot to examine the effects of S179D prolactin on endothelial cells
Wed Mar 01 00:00:00 UTC 2006
Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cells.
The Journal of biological chemistry
Lu JC,Piazza TM,Schuler LA
Fri Oct 07 00:00:00 UTC 2005
Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cells.
The Journal of biological chemistry
Lu JC,Piazza TM,Schuler LA
Fri Oct 07 00:00:00 UTC 2005
Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cells.
The Journal of biological chemistry
Lu JC,Piazza TM,Schuler LA
Fri Oct 07 00:00:00 UTC 2005
Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
The Journal of steroid biochemistry and molecular biology
Gutzman JH,Miller KK,Schuler LA
35-9200 was used in western blot to study endogenous prolactin
Thu Jan 01 00:00:00 UTC 2004
Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.
Endocrinology
Schroeder MD,Brockman JL,Walker AM,Schuler LA
35-9200 was used in western blot to test if a mimic of phosphorylated human prolactin, S79D-PRL, initiates signaling in mammary tumor cells alone and in combination with unmodified prolactin.
Mon Dec 01 00:00:00 UTC 2003
